{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:40:59Z","timestamp":1788982859904,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.bbrc.2024.150395","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T05:57:58Z","timestamp":1720936678000},"page":"150395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Expression of the non-coding RNA nc886 facilitates the development of tyrosine kinase inhibitor resistance in EGFR-mutated non-small-cell lung cancer cells"],"prefix":"10.1016","volume":"731","author":[{"given":"Vivian N.V.","family":"Bui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina F.","family":"Daugaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9472-8099","authenticated-orcid":false,"given":"Boe S.","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4372-9961","authenticated-orcid":false,"given":"Anders L.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10299","key":"10.1016\/j.bbrc.2024.150395_bib1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2024.150395_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2018.02.006","article-title":"Acquired resistance to EGFR targeted therapy in non-small cell lung cancer: mechanisms and therapeutic strategies","volume":"65","author":"Lim","year":"2018","journal-title":"Cancer Treat Rev."},{"issue":"9","key":"10.1016\/j.bbrc.2024.150395_bib3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/14737140.2020.1806716","article-title":"Lung cancer management: monitoring and treating resistance development in third-generation EGFR TKIs","volume":"20","author":"Franceschini","year":"2020","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.bbrc.2024.150395_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.602762","article-title":"Development of EGFR TKIs and options to manage resistance of third-generation EGFR TKI osimertinib: conventional Ways and immune Checkpoint inhibitors","volume":"10","author":"Wu","year":"2020","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.bbrc.2024.150395_bib5","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1038\/oncsis.2017.17","article-title":"MET amplification and epithelial-to-mesenchymal transition exist as parallel resistance mechanisms in erlotinib-resistant, EGFR-mutated, NSCLC HCC827 cells","volume":"6","author":"Jakobsen","year":"2017","journal-title":"Oncogenesis"},{"issue":"2","key":"10.1016\/j.bbrc.2024.150395_bib6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.21037\/tlcr.2016.04.07","article-title":"The role of epithelial to mesenchymal transition in resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer","volume":"5","author":"Jakobsen","year":"2016","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.bbrc.2024.150395_bib7","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3389\/fonc.2019.01044","article-title":"EMT-mediated acquired EGFR-TKI resistance in NSCLC: mechanisms and strategies","volume":"9","author":"Zhu","year":"2019","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.bbrc.2024.150395_bib8","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.tcb.2020.07.003","article-title":"EMT, MET, plasticity, and tumor metastasis","volume":"30","author":"Bakir","year":"2020","journal-title":"Trends Cell Biol."},{"issue":"18","key":"10.1016\/j.bbrc.2024.150395_bib9","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108647","article-title":"Dynamic EMT: a multi-tool for tumor progression","volume":"40","author":"Brabletz","year":"2021","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150395_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/1568009617666170203162556","article-title":"Epigenetic regulation of EMT in non-small cell lung cancer","volume":"18","author":"O'Leary","year":"2018","journal-title":"Curr. Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.bbrc.2024.150395_bib11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41556-018-0196-y","article-title":"Non-redundant functions of EMT transcription factors","volume":"21","author":"Stemmler","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150395_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.21037\/tlcr-22-507","article-title":"Genome-wide epigenetic and mRNA-expression profiling followed by CRISPR\/Cas9-mediated gene-disruptions corroborate the MIR141\/MIR200C-ZEB1\/ZEB2-FGFR1 axis in acquired EMT-associated EGFR TKI-resistance in NSCLC cells","volume":"12","author":"Vad-Nielsen","year":"2023","journal-title":"Transl. Lung Cancer Res."},{"issue":"3","key":"10.1016\/j.bbrc.2024.150395_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261481","article-title":"Methylation pattern of polymorphically imprinted nc886 is not conserved across mammalia","volume":"17","author":"Kostiniuk","year":"2022","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bbrc.2024.150395_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14112787","article-title":"Small but powerful: the human vault RNAs as multifaceted modulators of pro-survival characteristics and tumorigenesis","volume":"14","author":"Gallo","year":"2022","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.bbrc.2024.150395_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084251","article-title":"Are we studying non-coding RNAs correctly? Lessons from nc886","volume":"23","author":"Lee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bbrc.2024.150395_bib16","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1261\/rna.2701111","article-title":"Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity","volume":"17","author":"Lee","year":"2011","journal-title":"RNA"},{"issue":"49","key":"10.1016\/j.bbrc.2024.150395_bib17","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1038\/onc.2017.285","article-title":"Epigenetic regulation of RNA polymerase III transcription in early breast tumorigenesis","volume":"36","author":"Park","year":"2017","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.bbrc.2024.150395_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24108533","article-title":"nc886, an RNA polymerase III-transcribed noncoding RNA whose expression is dynamic and regulated by intriguing mechanisms","volume":"24","author":"Lee","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"51","key":"10.1016\/j.bbrc.2024.150395_bib19","doi-asserted-by":"crossref","first-page":"E11970","DOI":"10.1073\/pnas.1815005115","article-title":"Mother-child transmission of epigenetic information by tunable polymorphic imprinting","volume":"115","author":"Carpenter","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"18","key":"10.1016\/j.bbrc.2024.150395_bib20","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2217\/epi-2022-0228","article-title":"Methylation status of VTRNA2-1\/nc886 is stable across populations, monozygotic twin pairs and in majority of tissues","volume":"14","author":"Marttila","year":"2022","journal-title":"Epigenomics"},{"issue":"1","key":"10.1016\/j.bbrc.2024.150395_bib21","doi-asserted-by":"crossref","DOI":"10.1080\/15592294.2024.2332819","article-title":"Non-coding 886 (nc886\/vtRNA2-1), the epigenetic odd duck - implications for future studies","volume":"19","author":"Raitoharju","year":"2024","journal-title":"Epigenetics"},{"issue":"1","key":"10.1016\/j.bbrc.2024.150395_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13148-021-01132-3","article-title":"Methylation status of nc886 epiallele reflects periconceptional conditions and is associated with glucose metabolism through nc886 RNAs","volume":"13","author":"Marttila","year":"2021","journal-title":"Clin. Epigenet."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150395_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13148-024-01673-3","article-title":"Epigenetics of the non-coding RNA nc886 across blood, adipose tissue and skeletal muscle in offspring exposed to diabetes in pregnancy","volume":"16","author":"Hjort","year":"2024","journal-title":"Clin. Epigenet."},{"issue":"12","key":"10.1016\/j.bbrc.2024.150395_bib24","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2026580118","article-title":"Oocyte age and preconceptual alcohol use are highly correlated with epigenetic imprinting of a noncoding RNA (nc886)","volume":"118","author":"Carpenter","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.bbrc.2024.150395_bib25","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/s41588-018-0232-7","article-title":"Insights into imprinting from parent-of-origin phased methylomes and transcriptomes","volume":"50","author":"Zink","year":"2018","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.bbrc.2024.150395_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052535","article-title":"VTRNA2-1: genetic variation, heritable methylation and disease association","volume":"22","author":"Dugue","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbrc.2024.150395_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10689-022-00325-w","article-title":"Heritable methylation marks associated with prostate cancer risk","volume":"22","author":"Dowty","year":"2023","journal-title":"Fam. Cancer"},{"issue":"13","key":"10.1016\/j.bbrc.2024.150395_bib28","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/pros.23654","article-title":"Heritable methylation marks associated with breast and prostate cancer risk","volume":"78","author":"Dugue","year":"2018","journal-title":"Prostate"},{"key":"10.1016\/j.bbrc.2024.150395_bib29","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.omto.2022.02.018","article-title":"A host non-coding RNA, nc886, plays a pro-viral role by promoting virus trafficking to the nucleus","volume":"24","author":"Saruuldalai","year":"2022","journal-title":"Mol Ther Oncolytics"},{"issue":"4","key":"10.1016\/j.bbrc.2024.150395_bib30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1261\/rna.060269.116","article-title":"Human noncoding RNA 886 (nc886) adopts two structurally distinct conformers that are functionally opposing regulators of PKR","volume":"23","author":"Calderon","year":"2017","journal-title":"RNA"},{"issue":"2","key":"10.1016\/j.bbrc.2024.150395_bib31","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202254925","article-title":"Small noncoding vault RNA2-1 disrupts gut epithelial barrier function via interaction with HuR","volume":"24","author":"Ma","year":"2023","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150395_bib32","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/s41467-018-03556-7","article-title":"nc886 is induced by TGF-beta and suppresses the microRNA pathway in ovarian cancer","volume":"9","author":"Ahn","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbrc.2024.150395_bib33","doi-asserted-by":"crossref","first-page":"e1558","DOI":"10.1002\/wrna.1558","article-title":"Protein kinase R and its cellular regulators in cancer: an active player or a surveillant?","volume":"11","author":"Lee","year":"2020","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"17","key":"10.1016\/j.bbrc.2024.150395_bib34","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1073\/pnas.1814510116","article-title":"Mechanism mediated by a noncoding RNA, nc886, in the cytotoxicity of a DNA-reactive compound","volume":"116","author":"Kunkeaw","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bbrc.2024.150395_bib35","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1080\/15384101.2021.2020431","article-title":"Nc886 promotes renal cancer cell drug-resistance by enhancing EMT through Rock2 phosphorylation-mediated beta-catenin nuclear translocation","volume":"21","author":"Gao","year":"2022","journal-title":"Cell Cycle"},{"issue":"5827","key":"10.1016\/j.bbrc.2024.150395_bib36","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1141478","article-title":"MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling","volume":"316","author":"Engelman","year":"2007","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.bbrc.2024.150395_bib37","doi-asserted-by":"crossref","first-page":"33300","DOI":"10.18632\/oncotarget.16350","article-title":"IGF1R depletion facilitates MET-amplification as mechanism of acquired resistance to erlotinib in HCC827 NSCLC cells","volume":"8","author":"Hussmann","year":"2017","journal-title":"Oncotarget"},{"issue":"75","key":"10.1016\/j.bbrc.2024.150395_bib38","doi-asserted-by":"crossref","first-page":"75ra26","DOI":"10.1126\/scitranslmed.3002003","article-title":"Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors","volume":"3","author":"Sequist","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.bbrc.2024.150395_bib39","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/cbin.12071","article-title":"RGMb impacts partial epithelial-mesenchymal transition and BMP2-Induced ID mRNA expression independent of PD-L2 in nonsmall cell lung cancer cells","volume":"47","author":"Dorset","year":"2023","journal-title":"Cell Biol. Int."},{"issue":"5","key":"10.1016\/j.bbrc.2024.150395_bib40","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1142\/S0219720010004963","article-title":"Analysis of qPCR data by converting exponentially related Ct values into linearly related X0 values","volume":"8","author":"Thomsen","year":"2010","journal-title":"J. Bioinf. Comput. Biol."},{"issue":"D1","key":"10.1016\/j.bbrc.2024.150395_bib41","doi-asserted-by":"crossref","first-page":"D853","DOI":"10.1093\/nar\/gky1095","article-title":"The UCSC Genome Browser database: 2019 update","volume":"47","author":"Haeussler","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.bbrc.2024.150395_bib42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/CJI.0000000000000439","article-title":"An extended PD-L2 cytoplasmic domain results from alternative splicing in NSCLC cells","volume":"45","author":"Dietz","year":"2022","journal-title":"J. Immunother."},{"issue":"11","key":"10.1016\/j.bbrc.2024.150395_bib43","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.18632\/oncotarget.2047","article-title":"nc886, a non-coding RNA of anti-proliferative role, is suppressed by CpG DNA methylation in human gastric cancer","volume":"5","author":"Lee","year":"2014","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.bbrc.2024.150395_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201796","article-title":"NF-kappaB activation is an early event of changes in gene regulation for acquiring drug resistance in human adenocarcinoma PC-9 cells","volume":"13","author":"Fukuoka","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbrc.2024.150395_bib45","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.celrep.2015.03.012","article-title":"NF-kappaB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer","volume":"11","author":"Blakely","year":"2015","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.bbrc.2024.150395_bib46","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.3892\/or.2016.5024","article-title":"Foxp3 downregulation in NSCLC mediates epithelial-mesenchymal transition via NF-kappaB signaling","volume":"36","author":"Wang","year":"2016","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.bbrc.2024.150395_bib47","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1038\/oncsis.2013.4","article-title":"A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop","volume":"2","author":"Ware","year":"2013","journal-title":"Oncogenesis"},{"issue":"415","key":"10.1016\/j.bbrc.2024.150395_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao4307","article-title":"Stress hormones promote EGFR inhibitor resistance in NSCLC: implications for combinations with beta-blockers","volume":"9","author":"Nilsson","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.bbrc.2024.150395_bib49","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1158\/1078-0432.CCR-22-3379","article-title":"IL6 mediates suppression of T- and NK-cell function in EMT-associated TKI-resistant EGFR-mutant NSCLC","volume":"29","author":"Patel","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"35","key":"10.1016\/j.bbrc.2024.150395_bib50","doi-asserted-by":"crossref","first-page":"15535","DOI":"10.1073\/pnas.1009472107","article-title":"TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer","volume":"107","author":"Yao","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150395_bib51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s42003-022-03111-7","article-title":"Ibrutinib reverses IL-6-induced osimertinib resistance through inhibition of Laminin alpha5\/FAK signaling","volume":"5","author":"Li","year":"2022","journal-title":"Commun. Biol."},{"issue":"10","key":"10.1016\/j.bbrc.2024.150395_bib52","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1158\/1078-0432.CCR-13-2613","article-title":"Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal","volume":"20","author":"Li","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2024.150395_bib53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cytogfr.2018.04.002","article-title":"Cross-talk between EGFR and IL-6 drives oncogenic signaling and offers therapeutic opportunities in cancer","volume":"41","author":"Ray","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bbrc.2024.150395_bib54","doi-asserted-by":"crossref","first-page":"182","DOI":"10.12688\/f1000research.28510.2","article-title":"Pan-cancer chromatin analysis of the human vtRNA genes uncovers their association with cancer biology","volume":"10","author":"Fort","year":"2021","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/j.bbrc.2024.150395_bib55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13148-020-0821-z","article-title":"DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer","volume":"12","author":"Galle","year":"2020","journal-title":"Clin. Epigenet."},{"issue":"8","key":"10.1016\/j.bbrc.2024.150395_bib56","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1158\/1078-0432.CCR-11-2635-T","article-title":"DNA methylation profiling defines clinically relevant biological subsets of non-small cell lung cancer","volume":"18","author":"Walter","year":"2012","journal-title":"Clin. Cancer Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24009318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24009318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T10:44:49Z","timestamp":1728470689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24009318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":56,"alternative-id":["S0006291X24009318"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150395","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of the non-coding RNA nc886 facilitates the development of tyrosine kinase inhibitor resistance in EGFR-mutated non-small-cell lung cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"150395"}}